WSGR logoWSGR logo
Alexandra Keck
Associate
Antitrust and Competition
Washington, D.C.

D202-791-8006

Download vCard
Open PDF

Alexandra Keck is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s antitrust practice. Her work focuses on a broad array of antitrust issues, including government investigations, antitrust litigation, competition concerns in mergers and acquisitions, and business counseling. Alexandra has represented leading companies in numerous industries, including pharmaceuticals, digital advertising, semiconductors, telecommunications, hospitals, medical devices, and technology and software.

While attending law school, Alexandra interned for the Bureau of Competition at the Federal Trade Commission and externed for the Honorable Randolph Moss of the U.S. District Court for the District of Columbia. She also served as student counsel for the Appellate Courts Immersion Clinic at Georgetown University Law Center, where she worked on public-interest federal appellate litigation, and assisted as a law fellow in the Legal Research and Writing Program.

Alexandra is practicing virtually in Michigan, where she is licensed.

Experience

Alexandra Keck is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s antitrust practice. Her work focuses on a broad array of antitrust issues, including government investigations, antitrust litigation, competition concerns in mergers and acquisitions, and business counseling. Alexandra has represented leading companies in numerous industries, including pharmaceuticals, digital advertising, semiconductors, telecommunications, hospitals, medical devices, and technology and software.

While attending law school, Alexandra interned for the Bureau of Competition at the Federal Trade Commission and externed for the Honorable Randolph Moss of the U.S. District Court for the District of Columbia. She also served as student counsel for the Appellate Courts Immersion Clinic at Georgetown University Law Center, where she worked on public-interest federal appellate litigation, and assisted as a law fellow in the Legal Research and Writing Program.

Alexandra is practicing virtually in Michigan, where she is licensed.

Focus Areas
Recent Insights
Alerts
Jury Finds Gilead and Teva Did Not Engage in an Anticompetitive Pay-for-Delay Scheme for HIV Drugs
On June 30, 2023, a jury in the Northern District of California found Gilead and Teva not liable in a trial accusing the companies of engaging in an illegal reverse payment to delay generic versions of two HIV drugs, Truvada (emtricitabine/tenofovir) and Atripla (efavirenz-/-emtricitabine-/-tenofovir). Following a five-week trial and two days of deliberations, the jury found that the plaintiffs failed to show that: 1) Gilead had market power within a market that included Truvada and/or Atripla, and 2) Gilead made a reverse payment to Teva to delay the entry of generic competition.1 This case marks the third jury verdict in favor of defendants in reverse-payment cases since the 2013 FTC v. Actavis decision—there have been no verdicts for plaintiffs.2
Learn More
Alerts
DOJ Antitrust, OIG Announce Collaboration to Protect Healthcare Markets
On December 9, 2022, the Department of Justice Antitrust Division (DOJ) and the Office of the Inspector General (OIG) of the Department of Health and Human Services (HHS) announced they are joining forces to protect healthcare markets.1 The two agencies signed a memorandum of understanding (MOU) detailing how they will work together to protect healthcare consumers and workers from collusion, ensure compliance with applicable laws, and promote competition in healthcare markets. This effort signals the agencies' increased focus on policing violations in healthcare markets.
Learn More
View All
WSGR logo
Copyright © 2024 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.